Furthermore, the downregulation of the anti-apoptotic proteins XIAP and Bcl-xL involved in the occurrence of resistances in many malignancies like ALL or NHL [44-48] is markedly enhanced. This evidence concerns the gene BCL2L1 and non-Hodgkin lymphoma.